日本語English简体中文 繁體中文

4583 Chiome Bioscience Inc.カイオム・バイオサイエンスTSE Growth / Pharmaceuticals

0 posts

Chiome Bioscience Inc. (4583) at a glance

Code
4583
Company
Chiome Bioscience Inc.
Local name
カイオム・バイオサイエンス
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥75.0 -3.00 (-3.85%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Chiome Bioscience Inc. (4583) Stock Price History

Chiome Bioscience Inc. closed at ¥75.0 on Nov 20, 2026, −14.8% over 1 month, −40.0% over 1 year.

2026-11-10 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥94.0¥74.0Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥94.0Oct 21
1-Month Low¥74.0Nov 6
1-Week Change−2.6%vs Nov 13
1-Month Change−14.8%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥85,227 today (−14.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −14.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥75.0−3−3.85%
Nov 19 (Thu)¥78.0+0+0.00%
Nov 18 (Wed)¥78.0+3+4.00%
Nov 17 (Tue)¥75.0−4−5.06%
Nov 16 (Mon)¥79.0+2+2.60%
Nov 13 (Fri)¥77.0+1+1.32%
Nov 12 (Thu)¥76.0−1−1.30%
Nov 11 (Wed)¥77.0−5−6.10%
Nov 10 (Tue)¥82.0+4+5.13%
Nov 9 (Mon)¥78.0+4+5.41%
2026-11-10 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥112¥74.0Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥112Sep 4
3-Month Low¥74.0Nov 6
1-Month Change−14.8%vs Oct 20
3-Month Change−10.7%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥89,286 today (−10.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −10.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥75.0−3−3.85%
Nov 19 (Thu)¥78.0+0+0.00%
Nov 18 (Wed)¥78.0+3+4.00%
Nov 17 (Tue)¥75.0−4−5.06%
Nov 16 (Mon)¥79.0+2+2.60%
Nov 13 (Fri)¥77.0+1+1.32%
Nov 12 (Thu)¥76.0−1−1.30%
Nov 11 (Wed)¥77.0−5−6.10%
Nov 10 (Tue)¥82.0+4+5.13%
Nov 9 (Mon)¥78.0+4+5.41%
2026-11-10 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥112¥66.0May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥112Sep 4
6-Month Low¥66.0Jun 23
3-Month Change−10.7%vs Aug 20
6-Month Change−14.8%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥85,227 today (−14.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −14.8%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥75.0−15.7%
Oct 2026¥89.0−17.6%
Sep 2026¥108+28.6%
Aug 2026¥84.0+21.7%
Jul 2026¥69.0−12.7%
Jun 2026¥79.0−6.0%
May 2026¥84.0−16.0%
2026-11-10 2026年12月期 第3四半期決算短信〔日本基準〕(非連結)¥126¥66.0Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥126Nov 28
52-Week Low¥66.0Jun 23
Year to Date−29.9%vs Dec 30
From 52-Week High−40.5%Nov 28

If you had invested ¥100,000 1 year ago, it would be worth ¥60,000 today (−40.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −40.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥75.0−15.7%
Oct 2026¥89.0−17.6%
Sep 2026¥108+28.6%
Aug 2026¥84.0+21.7%
Jul 2026¥69.0−12.7%
Jun 2026¥79.0−6.0%
May 2026¥84.0−16.0%
Apr 2026¥100−2.9%
Mar 2026¥103−8.0%
Feb 2026¥112+0.0%
Jan 2026¥112+4.7%
Dec 2025¥107−15.1%
Nov 2025¥126―
¥269¥67.0Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥269Dec 30, 2024
3-Year Low¥67.0Jun 19, 2026
Annualized Return−18.0%
Max Drawdown−75.1%

If you had invested ¥100,000 3 years ago, it would be worth ¥55,147 today (−44.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −44.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥75.0−29.9%
2025¥107―
¥269¥67.0Nov 29, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥269Dec 30, 2024
5-Year Low¥67.0Jun 19, 2026
Annualized Return−18.3%
Max Drawdown−75.1%

If you had invested ¥100,000 5 years ago, it would be worth ¥36,585 today (−63.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +101.3%, while this stock moved −63.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥75.0−29.9%
2025¥107―
¥4,875¥69.0Jan 1, 2012Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥4,875Apr 2013
All-Time Low¥69.0Jul 2026
Total Change−73.3%vs Jan 2012
Annualized Return−8.5%

If you had invested ¥100,000 in Jan 2012, it would be worth ¥26,667 today (−73.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +459.7%, while this stock moved −73.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥75.0−29.9%
2025¥107−60.2%
2024¥269+99.3%
2023¥135−24.2%
2022¥178−8.7%
2021¥195+4.8%
2020¥186−7.9%
2019¥202+7.4%
2018¥188−46.1%
2017¥349−24.5%
2016¥462−26.1%
2015¥625−55.0%
2014¥1,388−13.9%
2013¥1,613−22.3%
2012¥2,075―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2012). Please check the latest prices before trading.

Chiome Bioscience Inc. (4583) financial indicators

PBR
4.08
Dividend yield
0.00%

See all financial indicators for Chiome Bioscience Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Chiome Bioscience Inc. (4583)

Business overview

The company is a biotech working on antibody drug discovery. Using its own technology platform and other antibody and protein technologies, it researches and develops antibody drugs for diseases where treatment satisfaction is still low, such as pancreatic cancer, lung cancer, Alzheimer's disease and ALS.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR4.08xAbove the sector median of 1.86x (No. 62 from the lowest)
Market cap¥6.1 bnNo. 56 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1262025/11/28
52-week low¥666/25
Current position15.0%Where the low is 0% and the high is 100% (close on 11/20: ¥75)
Year to date-29.9%No. 53 of 77 in the sector (best first)
1 year-40.0%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers2 timesLatest: 10/21 (No. 49)
Top 50 losers1 timesLatest: 11/11 (No. 47)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (6).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Chiome Bioscience Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English